Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: ACTELION PHARMACEUTICALS US, INC.
Awarding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Funding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Period of performance: 2024-05-01 to 2024-06-30
Current total value of award: $11863.58
Description: CURASCRIPT, ADEMPAS 1MG 90-COUNT, FY24